Nuwellis (NUWE) Interest Coverage Ratio (2015 - 2025)
Nuwellis (NUWE) reported Interest Coverage Ratio of 66.52 for Q1 2025, up 486.92% on a YoY basis from 11.33 in Q1 2024, and up 486.92% quarter-over-quarter from 11.33 in Q1 2024.
Nuwellis (NUWE) Interest Coverage Ratio (2015 - 2025) Analysis & Trends
Nuwellis has reported Interest Coverage Ratio for 4 years, with the latest figure at 66.52 in Q1 2025.
- For the quarter ending Q1 2025, Interest Coverage Ratio rose 486.92% year-over-year to 66.52; the trailing twelve-month figure through Dec 2025 stood at 79.96 (up 204.89% YoY), and the FY2025 full-year result was 0.57, up 99.08% from the prior year.
- Interest Coverage Ratio for Q1 2025 stood at 66.52, up from 11.33 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 66.52 in Q1 2025, with the low at 11.33 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 7.73 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 8.09 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 12.23 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -2.90 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 5.36 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 20.98 |
| 10 | Nuwellis | 279,710.00 | -1.80 Mn | 1.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 66.52 |
| Mar 31, 2024 | 11.33 |
| Sep 30, 2016 | -59.74 |
| Jun 30, 2016 | -3,982.00 |
| Mar 31, 2016 | -19.89 |
| Dec 31, 2015 | 43.01 |
| Sep 30, 2015 | -22.40 |
| Jun 30, 2015 | -40.90 |
| Mar 31, 2015 | -110.98 |